Dr. John Gallagher

Faculty Staff Profile Image
Associate Professor
Office Location: 
Historic Jenkins School of Behavioral Sciences

Curriculum Vitae

Biographical Sketch

Dr. John R. Gallagher is an Associate Professor in the School of Social Work at Morgan State University. Dr. Gallagher teaches in the Master of Social Work (MSW) Department. His expertise is in clinical social work, substance use disorder and mental health treatment and recovery, and policy analysis and advocacy.

Dr. Gallagher's research agenda is focused on the use of medication-assisted treatment (MAT) in treating opioid use disorders; exploring drug court, and other treatment court participants' lived experiences in programming; identifying the factors that may contribute to racial disparities in treatment court outcomes; program evaluation for drug courts and other treatment courts; and implementing evidence-based interventions to promote substance use disorder and mental health recovery. He serves as Associate Editor for Alcoholism Treatment Quarterly, is on the editorial board for the Journal for Advancing Justice, and has been invited to serve as a peer-reviewer for over 30 academic journals. Dr. Gallagher has developed a national reputation for excellence in drug court research, and he helped develop the Racial and Ethnic Disparities (RED) Program Assessment Tool, presents the equity and inclusion curriculum for the National Association of Drug Court Professionals (NADCP), and advocates for best-practice standards in serving African Americans in drug court. Dr. Gallagher is a Licensed Clinical Social Worker (LCSW) and Licensed Clinical Addiction Counselor (LCAC) who has practiced substance use disorder and mental health counseling since 2002.

Professional/Research Interests

Substance Use Disorder and Mental Health Treatment and Recovery; Qualitative Research; Drug Court and other Treatment Courts; African Americans' Lived Experiences in Drug Court; Criminal Justice Reform

Recent Publications

Gallagher, J. R., Wahler, E. A., & Lefebvre, E. (2020). Further evidence of racial disparities in drug court outcomes: Enhancing service-delivery to reduce criminal recidivism rates for non-White participants. Journal of Social Service Research, 46(3), 406-415.

Gallagher, J. R., Nordberg, A., Minasian, R., Szymanowski, S., Carlton, J., Fee, K., ... Paiano, T. (2020). Community-engaged research (CER) as the avenue to promoting well-being and recovery in drug court. ENGAGE! Co-created Knowledge Serving the State, 1(2), 24-34.

Gallagher, J. R., Nordberg, A., Deranek, M. S., & Minasian, R. M. (2019). Drug court through the lenses of African American women: Improving graduation rates with gender-responsive interventions. Women & Criminal Justice, 29(6), 323-337.

Gallagher, J. R., Nordberg, A., Szymanowski, S., & Malone, S. E. (2019). A behind-the-scenes perspective on the key components of drug court: A narrative analysis. Journal of Human Behavior in the Social Environment, 29(7), 909-921.

Gallagher, J. R. (2019). Issue brief: Racial and ethnic disparities (RED) in treatment courts. Washington, DC: American University, Justice Programs Office, School of Public Affairs.

Gallagher, J. R., Marlowe, D. B., & Minasian, R. M. (2019). Participant perspectives on medication-assisted treatment for opioid use disorders in drug court. Journal for Advancing Justice, 2, 39-54.

Gallagher, J. R., Wahler, E. A., Minasian, R. M., & Edwards, A. (2019). Treating opioid use disorders in drug court: Participants' views on using medication-assisted treatments (MATs) to support recovery. International Criminal Justice Review, 29(3), 249-261.

Gallagher, J. R., Nordberg, A., Dibley, A. R. (2019). Improving graduation rates for African Americans in drug court: Importance of human relationships and barriers to gaining and sustaining employment. Journal of Ethnicity in Substance Abuse, 18(3), 387-401.

Gallagher, J. R., Whitmore, T. D., Horsley, J., Marshall, B., Deranek, M., Callantine, S., & Woodward Miller, J. (2019). A perspective from the field: Five interventions to combat the opioid epidemic and ending the dichotomy of harm reduction versus abstinence-based programs. Alcoholism Treatment Quarterly, 37(3), 404-417. 

Current Courses

SOWK 509